http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2477267-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_253de143b03bc8ee2bf61b3c64e32c35
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-40
filingDate 2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc317ccfb3301b44c620993bdaab8277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dfc3961507bef46256767bec2216c53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62c977bfef4b2f3d6e33dbbab85d1142
publicationDate 2013-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2477267-C2
titleOfInvention Water-soluble arylated c70 fullerene derivatives and method for production thereof
abstract FIELD: chemistry. n SUBSTANCE: invention relates to chemical industry and chemical functionalisation of fullerene C 70 , particularly a method for synthesis of organic derivatives of [70] fullerene, including those soluble in water and physiological media. More specifically, the invention relates to novel water-soluble derivatives of fullerene C 70 of general formula , where in general formula 1, X denotes a methylene group (CH 2 ), oxygen (O), sulphur (S), nitrogen (NH or NR, where R is an aliphatic acid residue -(CH 2 ) m COOH, where m ranges from 1 to 99); the number of methylene links n in the chain which binds the solubilising COOH group and a C 6 H 4 X fragment ranges from 0 to 99; as well as to a method of producing water-soluble arylated C 70 fullerene derivatives of general formula 1 upon reaction of chlorofullerenes with aromatic acid esters followed by hydrolysis, where the chlorofullerenes used are C 70 C 18 and/or C 70 Cl 10 chlorofullerenes. n EFFECT: invention can be used in biomedical research and in production of novel medical drugs for therapy in human and animal diseases. n 2 cl, 3 ex, 5 dwg
priorityDate 2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412117526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420312848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415728733
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411173879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16131935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566570

Total number of triples: 45.